---
title: Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical remission
  in Crohn's disease and ulcerative colitis - 54 week data.
authors:
- Tamás Molnár
- Klaudia Farkas
- Mariann Rutka
- Tamás Ferenci
- Ferenc Nagy
- Anita Bálint
- Renáta Bor
- Ágnes Milassin
- Anna Fábián
- Z Végh
- Zsuzsanna Kürti
- Péter László Lakatos
- Zoltán Szepes
date: '2017-01-01'
publishDate: '2024-01-29T15:58:20.796673Z'
publication_types:
- article-journal
publication: '*JOURNAL OF CROHNS & COLITIS*'
doi: 10.1093/ecco-jcc/jjx002.799
links:
- name: URL
  url: https://m2.mtmt.hu/api/publication/3215143
---
